As part of this initiative, Invest UP — the state’s nodal investment promotion agency — is organising a series of global roadshows and strategic business engagements across the United States, Europe, ...

At the Paris Air Show at Le Bourget, Orbex chief executive Miguel Bello Mora announced that the company is now targeting next ...

As the UK market grapples with the repercussions of faltering trade data from China, the FTSE 100 and FTSE 250 indices have experienced declines, reflecting broader global economic concerns. In such a ...

The unpredictable ‘Leader of the free world’, through his actions dictated by the obsession to ‘Make America Great Again’, ...

Human Magic, the global employer brand agency behind creative strategies for brands like Nike, Microsoft, Apple, LinkedIn, and AstraZeneca, today announces that TapIn, the award-winning Gen Z-focused ...

Neurofibromatosis Type 2 Market Insight, Epidemiology And Market Forecast - 2034The Neurofibromatosis Type 2 treatment market is experiencin ...

Use of an investigational monoclonal antibody called bimagrumab added to semaglutide produced weight loss while preserving ...

The Business Research Company The Business Research Company's Estrogen Receptor Modulators Global Market Report 2025 – Market Size, Trends, ...

AstraZeneca’s corporate headquarters were chosen to be in London, United Kingdom, while its R&D headquarters were to be in Sweden, with major centres of excellence in the UK and USA.

HSBC and Shell are the only two British companies in the top 100 of Forbes’ Global 2000, but its presence grows with 68 scattered throughout the list.

The market, which was valued at $0.85 billion in 2024, is projected to grow to $0.91 billion in 2025, representing a compound annual growth rate CAGR of 7.2%. The growth during this historic period ...

In the historic period, the growth can be attributed to the increasing prevalence of chronic diseases, heightening demand for targeted therapies, advancements in drug delivery systems and enhanced ...